Josefin Landgård
Angel Investor
Stockholm, Sweden
Josefin Landgård is a seed investor in Stockholm focused on Health Care and Mobile. Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Josefin Landgård invests in
Stages Josefin Landgård invests in
Countries Josefin Landgård invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $400k–$5.5M
- Pre-Seed
- $618k–$1.1M
Investment Focus
Industry
- Health Care 5 (45%)
- Mobile 2 (18%)
- Medical 2 (18%)
- Women's 2 (18%)
- Personal Health 2 (18%)
Stage
- Seed 6 (55%)
- Pre-Seed 2 (18%)
- Angel 1 (9%)
- Series A 1 (9%)
- Funding Round 1 (9%)
Country
- Sweden 6 (55%)
- France 1 (9%)
- United Kingdom 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Noala is a listen to community so that together its creating the simplest and most effective platform for speech and language therapists. | $3.9M / Seed / Oct 19, 2022 | ||
| Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets | $11.6M / Series A / May 20, 2022 | ||
| Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets | $2.3M / Seed / Oct 07, 2021 | ||
| Medoma is a virtual acute ward that offers tech-enabled acute care in the patient's home through its hospital home services. It provides medical equipment, staff, and tools that enable monitoring health care of the patients at home. | $1.1M / Pre-Seed / Sep 16, 2021 | ||
| Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets | $617.6K / Pre-Seed / Dec 08, 2020 | ||
| Estrid is a Scandinavian razor and body care brand that offers reasonably priced, high-quality vegan products. It intended for its stainless steel razor to last a lifetime. Its moisturizing strips, which are designed to make skin feel good, are free of animal byproducts. | $18M / Dec 06, 2020 | ||
| Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet. | $2.1M / Seed / Jan 19, 2020 | ||
| We are experts in tech, working alongside experts in fertility. These partnerships have fostered a vision of democratising fertility care for the future. We believe that everyone should have access to reliable and affordable fertility care. | $5.5M / Seed / Nov 18, 2019 | ||
| Grace Health is the first women’s health platform designed for emerging markets and was founded in 2018 by Swedish entrepreneurs Estelle Westling and Thérèse Mannheimer. The app creates a safe environment for health information for women with low health literacy and low digital literacy. It has been awarded by Fast Company and Wired as the topinnovations in the Nordics. The Grace Health platform has over 1.3 million registered users in Ghana, Nigeria, Kenya and South Africa and sold to Penda Health, one of Kenya's largest health care providers in November of 2023. More here https://medium.com/grace-health-insights/kenyan-medical-care-chain-penda-acquires-impact-startup-grace-health-to-bolster-its-on-demand-cd019fbda5a1. | $400K / Seed / Feb 08, 2019 | ||
| With over 6,000 languages spoken worldwide and ever-increasing migration, language barriers are a major and growing problem globally. The healthcare sector's efforts to solve the problem have so far consisted of expensive, medically unsafe and limited interpretation services that have led to high costs as well as inefficient and inadequatecare. Care to Translate develops a digital translation tool which solves the problem of language barriers for healthcare providers by providing safe and effective communication between healthcare professionals and patients who speak different languages thus lowering costs, increases patient safety, and makes healthcare more effective and equal for all. | $348K / Angel / Feb 06, 2019 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Josefin Landgård invest in?
Josefin Landgård invests primarily in Health Care, Mobile and Medical startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Josefin Landgård invest in?
Josefin Landgård typically joins rounds of $400k–$5.5M at Seed and $618k–$1.1M at Pre-Seed. These are whole funding-round sizes, not Josefin Landgård's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Josefin Landgård took part in.
How do I contact Josefin Landgård?
Public channels for Josefin Landgård include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Josefin Landgård last invest?
The most recent investment recorded for Josefin Landgård closed in Oct 2022. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
